Listen to the article
A St. Louis County woman has admitted to orchestrating an elaborate scheme that defrauded Missouri’s Medicaid program of nearly $175,000 through false claims for home health care services that were never provided.
Camille S. Childress, 41, entered a guilty plea to one count of health care fraud in federal court this week, acknowledging her role in a fraud that spanned two years and involved multiple layers of deception.
According to court documents, Childress began her fraudulent operation by submitting falsified documentation to enroll her company, Inspiring Angels LLC, as an authorized Missouri Medicaid provider. The application deliberately misidentified another individual as the owner of the business, a calculated move to conceal Childress’s involvement due to her 2012 criminal conviction that would have disqualified her from program participation.
Federal prosecutors detailed how Childress then systematically submitted claims seeking reimbursement for home health care services that were completely fabricated. In several instances, patients for whom she billed were actually hospitalized during the times she claimed to be providing in-home care—making the provision of such services physically impossible.
Investigators from multiple agencies uncovered numerous additional claims for which Childress could produce no supporting documentation, such as timesheets or service records, that would verify any care had actually been delivered.
“Health care fraud schemes like this one divert critical resources away from those who legitimately need care,” said a spokesperson for the U.S. Department of Health and Human Services Office of Inspector General, one of the agencies involved in the investigation. “These frauds ultimately harm taxpayers and vulnerable Medicaid recipients.”
The Missouri Medicaid Fraud Control Unit, which participated in the investigation, reported that the state’s Medicaid program disbursed at least $174,496 for fraudulent claims submitted by Childress during 2021 and 2022. The actual financial impact may be higher when accounting for administrative costs and investigative resources.
Health care fraud has become an increasing concern for federal and state authorities, with the U.S. Department of Justice estimating that fraud accounts for between 3% and 10% of all health care spending nationwide—potentially hundreds of billions of dollars annually.
Missouri’s Medicaid program, which provides health coverage for low-income residents, children, pregnant women, and people with disabilities, serves approximately 1.2 million residents with an annual budget exceeding $12 billion. The program relies heavily on honest providers to deliver necessary care while maintaining program integrity.
Childress is scheduled to appear for sentencing on June 16. She faces serious consequences for her actions, including a maximum penalty of up to 10 years in federal prison and a fine of up to $250,000, or both. The court will also order restitution to repay the fraudulently obtained funds.
The case was jointly investigated by the U.S. Department of Health and Human Services Office of Inspector General, the Missouri Medicaid Fraud Control Unit, and the Federal Bureau of Investigation, highlighting the multi-agency approach often required to combat health care fraud. Assistant U.S. Attorney Derek Wiseman is prosecuting the case.
This conviction comes amid increased scrutiny of home health care services nationwide, a sector that has seen explosive growth as the aging population increases demand for in-home support. The home health industry has become a frequent target for fraud due to less direct oversight compared to facility-based care.
Federal authorities have ramped up efforts to identify and prosecute Medicaid fraud in recent years, with the Justice Department recovering over $5.6 billion from health care fraud judgments and settlements in the past fiscal year alone.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.


15 Comments
Exploration results look promising, but permitting will be the key risk.
Production mix shifting toward False Claims might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Uranium names keep pushing higher—supply still tight into 2026.
Exploration results look promising, but permitting will be the key risk.
If AISC keeps dropping, this becomes investable for me.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.